GSK
GSK Plc ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$53.39
-0.89 ▼ -1.64%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$53.95
+0.56 ▲ +1.05%
| Index | - | P/E | 14.57 | EPS (ttm) | 3.66 | Insider Own | - | Shs Outstand | 2.01B | Perf Week | -2.05% |
| Market Cap | 106.95B | Forward P/E | 10.08 | EPS next Y | 10.2% | Insider Trans | - | Shs Float | 2.00B | Perf Month | -8.72% |
| Enterprise Value | 125.64B | PEG | 1.74 | EPS next Q | 1.17 | Inst Own | 20.53% | Short Float | 0.54% | Perf Quarter | 10.29% |
| Income | 7.53B | P/S | 2.48 | EPS this Y | 2.29% | Inst Trans | -2.87% | Short Ratio | 2.06 | Perf Half Y | 28.71% |
| Sales | 43.11B | P/B | 4.86 | EPS next 5Y | 5.79% | ROA | 9.61% | Short Interest | 10.81M | Perf YTD | 8.87% |
| Book/sh | 10.98 | P/C | 23.34 | EPS past 3/5Y | -25.93% 0.08% | ROE | 38.48% | 52W High | -13.46% ($61.69) | Perf Year | 36.09% |
| Cash/sh | 2.29 | P/FCF | 13.58 | Sales past 3/5Y | 6.03% -0.31% | ROIC | 18.01% | 52W Low | 64.89% ($32.38) | Perf 3Y | 59.28% |
| Dividend Est. | $1.94 (3.63%) | EV/EBITDA | 8.75 | EPS Y/Y TTM | 132.14% | Gross Margin | 72.53% | Volatility(W/M) | 2.05% 1.61% | Perf 5Y | 47.57% |
| Dividend TTM | 1.78 | EV/Sales | 2.91 | Sales Y/Y TTM | 7.51% | Oper. Margin | 22.57% | ATR (14) | 1.25 | Perf 10Y | 29.98% |
| Dividend Ex-Date | 2026/2/20 | Quick Ratio | 0.54 | EPS Q/Q | 61.53% | Profit Margin | 17.47% | RSI (14) | 37.22 | Recom | 2.57 |
| Dividend Gr. 3/5Y | 8.77% -7.68% | Current Ratio | 0.82 | Sales Q/Q | 10.17% | SMA20 | -7.32% ($57.61) | Beta | 0.48 | Target Price | $56.87 |
| Payout | 47.15% | Debt/Eq | 1.08 | Earnings | 2000000 | SMA50 | -1.65% ($54.29) | Rel Volume | 0.89 | Prev Close | $54.28 |
| Employees | 66841 | LT Debt/Eq | 0.9 | EPS/Sales Surpr. | 8.5% 3.23% | SMA200 | 17.72% ($45.35) | Avg Volume(3M) | 5.24M | Price | $53.39 |
| IPO | 1980/3/28 | Option/Short | Yes/Yes | Trades | 28666 | Volume | 4,661,240 | Change | -1.64% |
뉴스 로딩 중...